Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Civica Interested In Retired Or Withdrawn ANDAs
Seeks Talks With Manufacturers Over 250 ANDAs For Essential Medicines
Jan 20 2020
•
By
Akriti Seth
Civica stand ready to takeover ANDAs that may be retired or withdrawn • Source: Shutterstock
More from Strategy
More from Business